NM_014059.3:c.47C>A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_014059.3(RGCC):​c.47C>A​(p.Ala16Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000804 in 1,243,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A16V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 8.0e-7 ( 0 hom. )

Consequence

RGCC
NM_014059.3 missense, splice_region

Scores

2
1
15
Splicing: ADA: 0.006811
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.836

Publications

0 publications found
Variant links:
Genes affected
RGCC (HGNC:20369): (regulator of cell cycle) This gene is thought to regulate cell cycle progression. It is induced by p53 in response to DNA damage, or by sublytic levels of complement system proteins that result in activation of the cell cycle. The encoded protein localizes to the cytoplasm during interphase and to centrosomes during mitosis. The protein forms a complex with polo-like kinase 1. The protein also translocates to the nucleus in response to treatment with complement system proteins, and can associate with and increase the kinase activity of cell division cycle 2 protein. In different assays and cell types, overexpression of this protein has been shown to activate or suppress cell cycle progression. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.33117223).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014059.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RGCC
NM_014059.3
MANE Select
c.47C>Ap.Ala16Glu
missense splice_region
Exon 1 of 5NP_054778.2Q9H4X1-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RGCC
ENST00000379359.4
TSL:1 MANE Select
c.47C>Ap.Ala16Glu
missense splice_region
Exon 1 of 5ENSP00000368664.3Q9H4X1-1
RGCC
ENST00000888696.1
c.47C>Ap.Ala16Glu
missense
Exon 1 of 5ENSP00000558755.1
RGCC
ENST00000888694.1
c.47C>Ap.Ala16Glu
missense splice_region
Exon 1 of 5ENSP00000558753.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
8.04e-7
AC:
1
AN:
1243356
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
607894
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
23798
American (AMR)
AF:
0.00
AC:
0
AN:
10586
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16824
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27810
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53916
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
43630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4516
European-Non Finnish (NFE)
AF:
9.89e-7
AC:
1
AN:
1011626
Other (OTH)
AF:
0.00
AC:
0
AN:
50650
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.034
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
23
DANN
Benign
0.89
DEOGEN2
Benign
0.031
T
Eigen
Benign
0.14
Eigen_PC
Benign
0.029
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.43
T
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.33
T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.84
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
0.090
N
REVEL
Benign
0.20
Sift
Benign
0.070
T
Sift4G
Benign
0.28
T
Polyphen
0.99
D
Vest4
0.31
MutPred
0.27
Gain of solvent accessibility (P = 0.005)
MVP
0.32
MPC
0.76
ClinPred
0.33
T
GERP RS
2.9
PromoterAI
0.21
Neutral
Varity_R
0.25
gMVP
0.20
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0068
dbscSNV1_RF
Benign
0.096
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1231580164; hg19: chr13-42031890; API